Want to join the conversation?
$BMY 2Q15 Q&A: Fernandez of Leerink asked about features drove recommendations for utilization of CheckMate 12. Francis explained that the focus is really on maintaining efficacy in the combination. As far as efficacy is concerned, focused on durability of responses or overall survival or one year landmark survival and about therapeutic index.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.